𝔖 Bobbio Scriptorium
✦   LIBER   ✦

DEANOL IN SPONTANEOUS AND INDUCED DYSKINESIAS

✍ Scribed by Laterre, E.Christian; Fortemps, Ernest

Book ID
123313507
Publisher
The Lancet
Year
1975
Tongue
English
Weight
144 KB
Volume
305
Category
Article
ISSN
0140-6736

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Ineffectiveness of deanol in tardive dys
Ineffectiveness of deanol in tardive dyskinesia: A placebo controlled study
✍ C. Montigny; G. Chouinard; L. Annable πŸ“‚ Article πŸ“… 1979 πŸ› Springer 🌐 English βš– 536 KB

In a double-blind placebo-controlled study, deanol acetamidobenzoate, administered in doses up to 1.5 g q.d. for three weeks to chronic schizophrenic patients presenting moderate to severe tardive dyskinesia, failed to alleviate the dyskinetic movements. However, there was a tendency for a significa

Spontaneous dyskinesia in schizophrenia
Spontaneous dyskinesia in schizophrenia
✍ Fenton, W.S.; Wyatt, R.J.; McGlashan, T.H. πŸ“‚ Article πŸ“… 1995 πŸ› Elsevier Science 🌐 English βš– 108 KB
Fentanyl-induced dyskinesias
Fentanyl-induced dyskinesias
✍ Giselle Petzinger; Stephan A. Mayer; Serge Przedborski πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 249 KB
Levodopa-induced dyskinesias
Levodopa-induced dyskinesias
✍ Giovanni Fabbrini; Jonathan M. Brotchie; Francisco Grandas; Masahiro Nomoto; Chr πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 109 KB

## Abstract Levodopa‐induced dyskinesias (LID) are common and difficult to treat. This review focuses on three issues related to LID: clinical features, classification and rating, pathophysiology and pathogenesis, and management. The three primary clinical syndromes are OFF‐period dystonia, peak‐do